We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




New Embolic Device Provides Targeted Treatment

By HospiMedica International staff writers
Posted on 10 Dec 2020
Print article
Image: The GPX low viscosity, aqueous-based injectable embolic solution (Photo courtesy of Fluidx Medical Technology)
Image: The GPX low viscosity, aqueous-based injectable embolic solution (Photo courtesy of Fluidx Medical Technology)
A novel interventional embolization device can devascularize tumors by durable, long-term occlusion of the blood vessels supplying it.

The Fluidx Medical Technology (Salt Lake City, UT, USA) GPX embolic device is an injectable, low viscosity, aqueous-based solution that solidifies into a durable embolic material upon delivery, without requiring polymerization or dimethyl-sulfoxide (DMSO) precipitation. It is packaged in a ready-to-use syringe, requires less than one minute of preparation, and is delivered through standard off-the-shelf micro, small, and large catheters.
GPX is intended for minimally invasive super-selective embolization of tumors, internal bleeds, tumors, aneurysms, vascular malformations, uterine fibroids, varicose veins, and other uses. The non-cytotoxic particles are easy to visualize under fluoroscopic x-ray. An important element of GPX use is that it has been confirmed that it does not adhere to catheters, and thus cannot result in an accidental catheter entrapment that can be catastrophic for the patient. The GPX Embolic Device is currently intended for investigational use only.

“GPX is an advanced embolic technology that overcomes the challenges associated with other embolic devices,” said Libble Ginster, CEO of Fluidx Medical Technology. “GPX can be used effectively for distal penetration and occlusion of vessel networks, as well as proximal ‘one-and-done’ use in conjunction with coiling. We look forward to GPX's use to help a variety of peripheral and neurovascular patients.”

“We are impressed with the GPX embolic," said Andrew Holden, MD, director of interventional radiology at Auckland City Hospital (New Zealand). “We delivered GPX through a long, 150cm, 2.4F microcatheter from the patient's radial artery. GPX was easy to use, precise, and occluded the tumor well. We look forward to using GPX across a broad range of applications to improve patient care.”

Embolic devices include particles, coils, and liquids or glues. Particles are usually small polymer spheres injected thorough catheters which flow downstream with the blood flow and fill large spaces. Coils can create a plug to occlude flow, but lack precision, sometimes perforating the vessel, and often require numerous expensive deployments to occlude. Liquid embolics have advantages for certain procedures, but are associated with cytotoxicity, vascular inflammation, clumping, polymerization and precipitation.

Related Links:
Fluidx Medical Technology

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
12-Channel ECG
CM1200B
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Video Laryngoscope
SH-VL1

Print article

Channels

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.